Trending...
- Pray the News Launches to Transform American Christians' Relationship with News
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
- New AI Academy Helps Therapists Embrace Tech Without Losing Their Humanity
With an innovative move to combat semiconductor lead times, component availability issues, and the use of unreliable automotive and COTS parts in space, VORAGO introduces a readily available rad-tolerant Arm® Cortex-M0, VA10805, with TID protection up to 300 krad(Si) for the emerging space market.
AUSTIN, Texas - PennZone -- VORAGO Technologies (https://voragotech.com) today announced a product portfolio expansion to include a new radiation-tolerant Arm® Cortex-M0 MCU, VA10805, as a cost-competitive and high reliability solution for LEO, New Space, SmallSat and CubeSat markets.
"As commercialization of space continues to grow, so does the need for reliable, affordable, and immediately available component options for cost-sensitive aerospace projects and missions. VORAGO is proud to be a part of that venture. In recent times, the semiconductor industry has experienced major supply shortages and extensive lead times. Our team at VORAGO recognized this problem and have provided a solution. We are excited to bring to the market our immediately available radiation-tolerant, cost-effective VA10805. – Dr. Hannah Moore, Sr. Manager, Product Management, VORAGO Technologies
More on The PennZone
Created with VORAGO's patented HARDSIL® technology specifically to provide competitive radiation protection for space applications, the VA10805 provides significantly more total ionizing dose protection than competing products. The VA10805 is an ideal solution for LEO missions, CubeSat and SmallSat constellations in need of immediately available radiation-tolerant microcontroller capabilities.
VORAGO's VA10805 includes the following features and benefits:
"As commercialization of space continues to grow, so does the need for reliable, affordable, and immediately available component options for cost-sensitive aerospace projects and missions. VORAGO is proud to be a part of that venture. In recent times, the semiconductor industry has experienced major supply shortages and extensive lead times. Our team at VORAGO recognized this problem and have provided a solution. We are excited to bring to the market our immediately available radiation-tolerant, cost-effective VA10805. – Dr. Hannah Moore, Sr. Manager, Product Management, VORAGO Technologies
More on The PennZone
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- BeyondTrucks CEO Wins Gold Stevie® Award for Best Entrepreneur in Transportation
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
Created with VORAGO's patented HARDSIL® technology specifically to provide competitive radiation protection for space applications, the VA10805 provides significantly more total ionizing dose protection than competing products. The VA10805 is an ideal solution for LEO missions, CubeSat and SmallSat constellations in need of immediately available radiation-tolerant microcontroller capabilities.
VORAGO's VA10805 includes the following features and benefits:
- 50MHz Arm® Cortex® - M0
- Latch-up immunity with HARDSIL® Hardened by Process Technology
- Total Ionizing Dose (TID): 300 krad (Si)
- 23KB Data and 128KB Program Memory
- 1KB One Time Programmable Configuration Memory (OTP)
- Broad range of communication interfaces (I2C, UART, SPI)
- 24 Counter/Timers with Extensive Hardware/Software Triggering
- 56 Multiplexed GPIOs
- Operating temperature range: -55 to 125°C
- Easy-to-design development kit, with exceptional support and service offerings available
- To learn more or request a datasheet, visit VORAGO's Product Page.
Source: VORAGO Technologies
0 Comments
Latest on The PennZone
- Medwave Recognized Among Top 10 Medical Billing Companies in USA by MedicoLeads
- Hamvay-Lang and Lampone.hu Join Forces with AIMarketingugynokseg.hu to Elevate Hungarian Lifestyle Brands on the Global Stage
- Why HVAC Cleaning Is So Important In Philadelphia
- Google AI Quietly Corrects the Record on Republic of Aquitaine's Legal Sovereignty
- NYC Leadership Strategist Stacie Selise Launches Groundbreaking 4S Framework Series to Redefine Executive Excellence
- Make Innovation Matter: Support H.R.1's R&D Expensing Relief for American Small Businesses
- Agreement to Supply US-Based Defense Provider with Thin-Film Solar Tech for Orbital Application; Ascent Solar Technologies, Inc. (N A S D A Q: ASTI)
- Byrd Davis Alden & Henrichson Launches Independence Day Safe Ride Initiative with 500 Free Uber Credits
- VIP Vacations Recognized as a Top 50 Producer with Pleasant Holidays
- Big Butler Fair Announces 2025 Music Lineup and Grandstand Events
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
- Colorado Scenthound Locations Partner with Humane Colorado to Give Adopted Dogs a "Clean Start"
- Endoacustica Europe Unveils iPhone 13 Pro Max Spy Phone—Pure Hardware, Zero Software Changes
- Suzanne Harp named Managing Director in Texas, USA
- $10 Million Acquisition of GXR World Sports Assets Energizes Global Launch of Sports.com Super App by Online Lottery-Sports Game Provider: Lottery.com
- Shop American Made Goods: New Online Marketplace My American Goods Curates the Best of U.S. Made
- Penn Mutual Earns 2025 Great Place To Work Certification™
- Investor Spotlight: Cycurion, Inc. (N A S D A Q: CYCU) Secures $69M in Contracts Amid Surging Demand for AI-Powered Cybersecurity Solutions
- $328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health